Privacy Policy
Signals Blog

Contributors

Categories

An immune system and cancer immunotherapy primer

We (or maybe it’s just me) talk about cancer immunotherapy around here A LOT. It’s hard not to when there are so many new advancements in this field of cancer research! I thought it was time to provide a guide to cancer immunotherapy, highlighting some of the more...

Reflecting on and recapping ComSciConCAN 2022

This post is a collaborative effort, written by the ComSciConCAN2022 organizing committee: Katie Pullella, Ben Davis-Purcell, Shealin Murray, Shanzeh Mumtaz Ahmed and Francesco Zangari. When the inaugural ComSciConCAN took place in 2019 at McMaster University, it...

Right Turn: Seeking science distractions while on vacation

Hello from Alaska! I’m on vacation this week – hopefully you are as well. After many days at sea and lots of napping, reading, walking, spotting local wildlife, eating, Netflix and Wordle, it’s time for something that feels like work without being work. Since I...

Catching up with ExCellThera and co-founder Guy Sauvageau

Launched in June of 2015, ExCellThera is a clinical-stage biotechnology company making strides in developing robust and cost-effective processes for growing blood stem cells for therapeutic use, backed by award-winning proprietary technology. The company was founded...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!